Enhanced Respiratory Gas Delivery Systems through Synergistic Combinations

Publication ID: 24-11857727_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Enhanced Respiratory Gas Delivery Systems through Synergistic Combinations,” Published Technical Disclosure No. 24-11857727_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857727_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,727.

Summary of the Inventive Concept

This inventive concept integrates patient interface devices with a double-Y supporting structure with other distinct technologies, such as AI, IoT, blockchain, and new materials, to create a more powerful and efficient respiratory gas delivery system.

Background and Problem Solved

The original patent describes a patient interface device with a frame assembly having a double-Y supporting structure, which provides a comfortable and efficient way to deliver respiratory gases to patients. However, the original design has limitations in terms of real-time data analysis, secure data management, and personalized therapy recommendations. This inventive concept addresses these limitations by combining the patient interface device with advanced technologies to create a more comprehensive and effective respiratory gas delivery system.

Detailed Description of the Inventive Concept

The inventive concept comprises a patient interface device with a double-Y supporting structure, which is integrated with various technologies to enhance its functionality. For instance, an AI-powered gas flow controller optimizes gas delivery based on real-time patient data, while a blockchain-based data storage system ensures secure and transparent data management. Additionally, IoT sensors can be integrated into the device to monitor gas flow rates and transmit data to a remote monitoring system. The system can also be equipped with a nanomaterial-based gas filter for enhanced gas purification and a control unit for regulating gas flow and pressure. Furthermore, an AI-powered analytics engine can be used to predict patient outcomes, and a blockchain-based patient data management system can be employed for secure and transparent data sharing.

Novelty and Inventive Step

The novelty of this inventive concept lies in the synergistic combination of the patient interface device with advanced technologies, which provides a more comprehensive and effective respiratory gas delivery system. The inventive step is the integration of these distinct technologies to create a system that can optimize gas delivery, provide personalized therapy recommendations, and ensure secure data management.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include integrating the patient interface device with other technologies, such as machine learning algorithms, cloud-based data storage, or advanced materials for gas filtration. Variations of the system could also include different configurations of the double-Y supporting structure, different types of sensors, or alternative data analytics engines.

Potential Commercial Applications and Market

The enhanced respiratory gas delivery system has significant commercial potential in the healthcare industry, particularly in the fields of respiratory care, critical care, and home healthcare. The system's ability to provide personalized therapy recommendations, optimize gas delivery, and ensure secure data management makes it an attractive solution for healthcare providers and patients alike.

CPC Classifications

SectionClassGroup
A A61 A61M16/0683
A A61 A61M16/0605
A A61 A61M16/0057
A A61 A61M16/0666
A A61 A61M16/0816
A A61 A61M16/0875

Original Patent Information

Patent NumberUS 11,857,727
TitlePatient interface device with a frame assembly having a double-Y supporting structure
Assignee(s)Koninklijke Philips N.V.